Laurie Keating, SVP, GC and Secretary at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 40,000 shares at $136.50 ($5.4M) on 2017-12-01, disclosed to the SEC on 2017-12-05.
Open-market sale of $5.4M ALNY by SVP, GC and Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $133.37 | 2,800 | $373K | 6.9% |
| 2 | $134.59 | 3,801 | $512K | 9.4% |
| 3 | $134.59 | 3,801 | $512K | 9.4% |
| 4 | $135.56 | 7,500 | $1.0M | 18.7% |
| 5 | $136.50 | 9,700 | $1.3M | 24.3% |
| 6 | $137.29 | 6,199 |
| $851K |
| 15.6% |
| 7 | $137.29 | 6,199 | $851K | 15.6% |
| Total | $135.99 avg | 40,000 | $5.4M | 100% |
| Filing → |
| ALNY | SELL | 2021-08-09 | $1.9M | — | Filing → |
| IMRX | BUY | 2021-08-04 | $105K | — | Filing → |
| ALNY | SELL | 2021-07-14 | $1.2M | — | Filing → |